Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger

Reproductive BioMedicine Online

Volumn 28, Issue 3, 2014, Pages 359-368

  Derksen, L ^a   Tournaye, H ^a   Stoop, D ^a   Van Vaerenbergh, I ^b   Bourgain, C ^b   Polyzos, N P ^a   Haentjens, P ^c   Blockeel, C ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

clomiphene citrate; GnRH agonist trigger; GnRH antagonist; IVF ICSI; ovarian stimulation; recombinant FSH

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DONOR; ENDOMETRIAL THICKNESS; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HISTOLOGY; HUMAN; HUMAN CELL; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE; OOCYTE RETRIEVAL; OVARIAN STIMULATION; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY;

CLOMIPHENE CITRATE; GNRH AGONIST TRIGGER; GNRH ANTAGONIST; IVF/ICSI; OVARIAN STIMULATION; RECOMBINANT FSH;

ADULT; CLOMIPHENE; COHORT STUDIES; ENDOMETRIUM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; OVULATION INDUCTION; PROGESTERONE;

EID: 84895424326     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2013.10.019     Document Type: Article

References (54)

1. R.F. Casper, and M.F. Mitwally Review: aromatase inhibitors for ovulation induction J. Clin. Endocrinol. Metab. 91 2006 760 771
2. R.F. Casper, and S.S. Yen Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor Science 205 1979 408 410
3. J.J. Cohen, C. Debache, F. Pigeau, J. Mandelbaum, M. Plachot, and J. de Brux Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles Fertil. Steril. 42 1984 360 365
4. M.D. Damewood, W. Shen, H.A. Zacur, W.D. Schlaff, J.A. Rock, and E.E. Wallach Disappearance of exogenously administered human chorionic gonadotropin Fertil. Steril. 52 1989 398 400
5. P. Devroey, N.P. Polyzos, and C. Blockeel An OHSS-free clinic by segmentation of IVF treatment Hum. Reprod. 26 2011 2593 2597
6. D.M. Duffy, D.R. Stewart, and R.L. Stouffer Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys J. Clin. Endocrinol. Metab. 84 1999 342 349
7. R.G. Edwards, P.C. Steptoe, and J.M. Purdy Establishing full-term human pregnancies using cleaving embryos grown in vitro Br. J. Obstet. Gynaecol. 87 1980 737 756
8. U. Elchalal, and J.G. Schenker The pathophysiology of ovarian hyperstimulation syndrome - views and ideas Hum. Reprod. 12 1997 1129 1137
9. J.C. Emperaire, I. Parneix, and A. Ruffie Luteal phase defects following agonist-triggered ovulation: a patient-dependent response Reprod. Biomed. Online 9 2004 22 27
10. L. Engmann, and C. Benadiva Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support Fertil. Steril. 97 2012 531 533
11. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil. Steril. 89 2008 84 91
12. H.M. Fatemi, B. Popovic-Todorovic, E. Papanikolaou, P. Donoso, and P. Devroey An update of luteal phase support in stimulated IVF cycles Hum. Reprod. Update 13 2007 581 590
13. H.M. Fatemi, D. Kyrou, C. Bourgain, E. Van den Abbeel, G. Griesinger, and P. Devroey Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle Fertil. Steril. 94 2010 2054 2058
14. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, J. Itskovitz-Eldor, and H.G. van Hooren Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J. Clin. Endocrinol. Metab. 87 2002 709 715
15. J.A. Garcia-Velasco Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos Fertil. Steril. 97 2012 527 528
16. M.P. Goldsman, A. Pedram, C.E. Dominguez, I. Ciuffardi, E. Levin, and R.H. Asch Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome Fertil. Steril. 63 1995 268 272
17. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J. Clin. Endocrinol. Metab. 71 1990 918 922
18. G. Griesinger, K. Diedrich, P. Devroey, and E.M. Kolibianakis GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis Hum. Reprod. Update 12 2006 159 168
19. P. Humaidan Agonist trigger: what is the best approach? Agonist trigger and low dose HCG Fertil. Steril. 97 2012 529 530
20. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, L. Westergaard, and C.Y. Andersen GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum. Reprod. 20 2005 1213 1220
21. P. Humaidan, L. Bungum, M. Bungum, and C. Yding Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod. Biomed. Online 13 2006 173 178
22. P. Humaidan, E.G. Papanikolaou, and B.C. Tarlatzis GnRHa to trigger final oocyte maturation: a time to reconsider Hum. Reprod. 24 2009 2389 2394
23. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
24. P. Humaidan, J. Quartarolo, and E.G. Papanikolaou Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil. Steril. 94 2010 389 400
25. P. Humaidan, S. Kol, and E.G. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum. Reprod. Update 17 2011 510 524
26. P. Humaidan, E.G. Papanikolaou, D. Kyrou, B. Alsbjerg, N.P. Polyzos, P. Devroey, and H.M. Fatemi The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives Reprod. Biomed. Online 24 2012 134 141
27. D.A. Imoedemhe, A.B. Sigue, E.L. Pacpaco, and A.B. Olazo Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization Fertil. Steril. 55 1991 328 332
28. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil. Steril. 56 1991 213 220
29. H.W. Jones Jr. What has happened? Where are we? Hum. Reprod. 11 1996 7 24 (discussion 29-31)
30. S. Kol Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil. Steril. 81 2004 1 5
31. S. Kol, and J. Itskovitz-Eldor Severe OHSS: yes, there is a strategy to prevent it! Hum. Reprod. 15 2000 2266 2267
32. E.M. Kolibianakis, and P. Devroey The luteal phase after ovarian stimulation Reprod. Biomed. Online 5 2002 26 35
33. E. Kolibianakis, C. Bourgain, C. Albano, K. Osmanagaoglu, J. Smitz, A. Van Steirteghem, and P. Devroey Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up Fertil. Steril. 78 2002 1025 1029
34. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, K. Diedrich, and G. Griesinger A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum. Reprod. 20 2005 2887 2892
35. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum. Reprod. Update 12 2006 651 671
36. P. Licht, V. Russu, S. Lehmeyer, and L. Wildt Molecular aspects of direct LH/HCG effects on human endometrium - lessons from intrauterine microdialysis in the human female in vivo Reprod. Biol. 1 2001 10 19
37. N.S. Macklon, R.L. Stouffer, L.C. Giudice, and B.C. Fauser The science behind 25 years of ovarian stimulation for in vitro fertilization Endocr. Rev. 27 2006 170 207
38. D. Martel, R. Frydman, M. Glissant, C. Maggioni, D. Roche, and A. Psychoyos Scanning electron microscopy of postovulatory human endometrium in spontaneous cycles and cycles stimulated by hormone treatment J. Endocrinol. 114 1987 319 324
39. M. Maruncic, and R.F. Casper The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women J. Clin. Endocrinol. Metab. 64 1987 148 152
40. R.W. Noyes, A.T. Hertig, and J. Rock Dating the endometrial biopsy Am. J. Obstet. Gynecol. 122 1975 262 263
41. K. Oktay, I. Turkcuoglu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod. Biomed. Online 20 2010 783 788
42. R. Orvieto Can we eliminate severe ovarian hyperstimulation syndrome? Hum. Reprod. 20 2005 320 322
43. C.V. Rao Multiple novel roles of luteinizing hormone Fertil. Steril. 76 2001 1097 1100
44. E. Shalev, Y. Geslevich, M. Matilsky, and M. Ben-Ami Gonadotrophin- releasing hormone agonist compared with human chorionic gonadotrophin for ovulation induction after clomiphene citrate treatment Hum. Reprod. 10 1995 2541 2544
45. V. Sharma, M. Whitehead, B. Mason, J. Pryse-Davies, T. Ryder, M. Dowsett, S. Campbell, and W. Collins Influence of superovulation on endometrial and embryonic development Fertil. Steril. 53 1990 822 829
46. J. Smitz, C. Bourgain, P. Devroey, M. Camus, A. Wisanto, and A.C. Van Stierteghem The luteal phase after GnRH analogues-HMG or clomiphene-HMG superovulation: endocrinology and endometrial morphology J.C. Alsina, GnRH y análogos en medicina reproductiva 1990 ESPAXS Barcelona
47. N. Sugino, S. Kashida, S. Takiguchi, A. Karube, and H. Kato Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy J. Clin. Endocrinol. Metab. 85 2000 3919 3924
48. A. Tavaniotou, C. Albano, J. Smitz, and P. Devroey Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist Fertil. Steril. 77 2002 733 737
49. S. Teramoto, and O. Kato Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study Reprod. Biomed. Online 15 2007 134 148
50. J. Tesarik, A. Hazout, and C. Mendoza Luteinizing hormone affects uterine receptivity independently of ovarian function Reprod. Biomed. Online 7 2003 59 64
51. T.H. Wang, S.G. Horng, C.L. Chang, H.M. Wu, Y.J. Tsai, H.S. Wang, and Y.K. Soong Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor J. Clin. Endocrinol. Metab. 87 2002 3300 3308
52. J.G. Whelan 3rd.; and N.F. Vlahos The ovarian hyperstimulation syndrome Fertil. Steril. 73 2000 883 896
53. C. Yding Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, L. Moore, and A.G. Byskov FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms Mol. Hum. Reprod. 5 1999 726 731
54. M.B. Zelinski-Wooten, J.S. Hutchison, D.L. Hess, D.P. Wolf, and R.L. Stouffer Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys Hum. Reprod. 10 1995 1658 1666